5 months 0.5 mg dutasteride, 0.5mg minoxidil
    3/6/2026

    From the encyclopedia
    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 0.5 mg 1x daily 5 months
    πŸ’Š Minoxidil (oral) 5 mg 1x daily 5 months
    the tone is πŸ˜€ positive with significant hair regrowth results.

    Other terms

    The user experienced significant hair regrowth after 5 months of using 0.5 mg dutasteride and 5 mg minoxidil daily. They reported no major side effects except for reduced libido.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Female Pattern Alopecia: Current Perspectives

      research Female pattern alopecia: current perspectives

      42 citations , August 2013 in “International Journal of Women's Health”
      This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.
      Hair Loss in Women: Comprehensive Overview and Treatment Options

      research Hair Loss in Women

      81 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”
      This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.
      Outcome Of Dutasteride 0.5mg In Androgenic Alopecia

      research Outcome of Dutasteride 0.5mg in Androgenic Alopecia

      December 2022 in “Scholars journal of applied medical sciences”
      This study concluded that dutasteride 0.5 mg/day improved hair growth in patients with androgenetic alopecia over six months but was associated with a higher prevalence of sexual dysfunction.
      5Ξ±-Reductase Inhibitors in Androgenetic Alopecia

      research 5Ξ±-Reductase inhibitors in androgenetic alopecia

      29 citations , September 2014 in “Current Opinion in Endocrinology, Diabetes and Obesity”
      This review discusses the efficacy and safety of 5-alpha reductase inhibitors for treating androgenetic alopecia, noting concerns about sexual side effects, which are typically uncommon and often resolve over time.
      Androgens in Women: Hormone-Modulating Therapies for Androgen-Mediated Cutaneous Disorders

      research Androgens in women

      34 citations , October 2018 in “Journal of The American Academy of Dermatology”
      This review discusses hormone-modulating therapies for androgen-mediated cutaneous disorders in women but reports no new clinical results and highlights the need for more rigorous studies.